BioCardia, Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioCardia, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-06-30 was $1.00K.
- BioCardia, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-09-30 was $0.00.
- BioCardia, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-06-30 was $0.00.
- BioCardia, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2021-06-30 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2023-06-30 | $1.00K 10-Q · filed 2023-11-08 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-08-12 | |
| 2019-03-31 | $1.00K 10-Q · filed 2019-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |